BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 35762427)

  • 21. Comparative Effectiveness of Nutritional and Biological Therapy in North American Children with Active Crohn's Disease.
    Lee D; Baldassano RN; Otley AR; Albenberg L; Griffiths AM; Compher C; Chen EZ; Li H; Gilroy E; Nessel L; Grant A; Chehoud C; Bushman FD; Wu GD; Lewis JD
    Inflamm Bowel Dis; 2015 Aug; 21(8):1786-93. PubMed ID: 25970545
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical progress in the two years following a course of exclusive enteral nutrition in 109 paediatric patients with Crohn's disease.
    Cameron FL; Gerasimidis K; Papangelou A; Missiou D; Garrick V; Cardigan T; Buchanan E; Barclay AR; McGrogan P; Russell RK
    Aliment Pharmacol Ther; 2013 Mar; 37(6):622-9. PubMed ID: 23360085
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictors of Response to Exclusive Enteral Nutrition in Newly Diagnosed Crohn´s Disease in Children: PRESENCE Study from SEGHNP.
    Moriczi M; Pujol-Muncunill G; Martín-Masot R; Jiménez Treviño S; Segarra Cantón O; Ochoa Sangrador C; Peña Quintana L; González Santana D; Rodríguez Martínez A; Rosell Camps A; Armas H; Barrio J; González de Caldas R; Rodríguez Salas M; Balmaseda Serrano E; Donat Aliaga E; Bodas Pinedo A; Vaquero Sosa E; Vecino López R; Solar Boga A; Moreno Álvarez A; Sánchez Sánchez C; Tolín Hernani M; Gutiérrez Junquera C; Martinón Torres N; Leis Trabazo MR; Eizaguirre FJ; García Peris M; Medina Benítez E; Fernández Caamaño B; Vegas Álvarez AM; Crespo Valderrábano L; Alonso Vicente C; Rubio Santiago J; Galera-Martínez R; García-Romero R; Ros Arnal I; Fernández Cebrián S; Lorenzo Garrido H; Viada Bris JF; Velasco Rodríguez-Belvis M; Bartolomé Porro JM; Blanco Rodríguez M; Barros García P; Botija G; Chicano Marín FJ; La Orden Izquierdo E; Crehuá-Gaudiza E; Navas-López VM; Martín-de-Carpi J
    Nutrients; 2020 Apr; 12(4):. PubMed ID: 32272604
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of exclusive enteral nutrition in complicated Crohn's disease.
    Yang Q; Gao X; Chen H; Li M; Wu X; Zhi M; Lan P; Hu P
    Scand J Gastroenterol; 2017 Sep; 52(9):995-1001. PubMed ID: 28598298
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Repeated exclusive enteral nutrition in the treatment of paediatric Crohn's disease: predictors of efficacy and outcome.
    Frivolt K; Schwerd T; Werkstetter KJ; Schwarzer A; Schatz SB; Bufler P; Koletzko S
    Aliment Pharmacol Ther; 2014 Jun; 39(12):1398-407. PubMed ID: 24779671
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exclusive Enteral Nutrition Therapy in Paediatric Crohn's Disease Results in Long-term Avoidance of Corticosteroids: Results of a Propensity-score Matched Cohort Analysis.
    Connors J; Basseri S; Grant A; Giffin N; Mahdi G; Noble A; Rashid M; Otley A; Van Limbergen J
    J Crohns Colitis; 2017 Sep; 11(9):1063-1070. PubMed ID: 28575325
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of exclusive enteral nutrition on the mucosal healing of different gastrointestinal segments in children with Crohn's disease.
    Tang WJ; Shi P; Xia HJ; Wu J; Wang YH; Huang Y
    J Dig Dis; 2024 Feb; 25(2):123-132. PubMed ID: 38556364
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The use of exclusive enteral nutrition for induction of remission in children with Crohn's disease demonstrates that disease phenotype does not influence clinical remission.
    Buchanan E; Gaunt WW; Cardigan T; Garrick V; McGrogan P; Russell RK
    Aliment Pharmacol Ther; 2009 Sep; 30(5):501-7. PubMed ID: 19549288
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of Exclusive Enteral Nutrition and Corticosteroid Induction Therapy on the Gut Microbiota of Pediatric Patients with Inflammatory Bowel Disease.
    Hart L; Farbod Y; Szamosi JC; Yamamoto M; Britz-McKibbin P; Halgren C; Zachos M; Pai N
    Nutrients; 2020 Jun; 12(6):. PubMed ID: 32517036
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exclusive Enteral Nutrition: Clinical Effects and Changes in Mucosal Cytokine Profile in Pediatric New Inflammatory Bowel Disease.
    Rolandsdotter H; Jönsson-Videsäter K; L Fagerberg U; Finkel Y; Eberhardson M
    Nutrients; 2019 Feb; 11(2):. PubMed ID: 30781421
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exclusive Enteral Nutrition versus Infliximab in Inducing Therapy of Pediatric Crohn's Disease.
    Luo Y; Yu J; Lou J; Fang Y; Chen J
    Gastroenterol Res Pract; 2017; 2017():6595048. PubMed ID: 28928769
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reverse-engineered exclusive enteral nutrition in pediatric Crohn's disease: A pilot trial.
    Lee D; Braly K; Nuding M; Braly I; Hopp C; Twible H; Pope C; Hayden HS; Hoffman L; Zheng H; Wahbeh G; Suskind DL
    J Pediatr Gastroenterol Nutr; 2024 May; 78(5):1135-1142. PubMed ID: 38558411
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic Efficacy of Oral Enteral Nutrition in Pediatric Crohn's Disease: A Single Center Non-Comparative Retrospective Study.
    Kim HJ; Kim Y; Cho JM; Oh SH; Kim KM
    Yonsei Med J; 2016 Sep; 57(5):1185-91. PubMed ID: 27401650
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exclusive enteral nutrition for induction of remission in anti-tumor necrosis factor refractory adult Crohn's disease: the Indian experience.
    Sood A; Singh A; Sudhakar R; Midha V; Mahajan R; Mehta V; Gupta YK; Kaur K
    Intest Res; 2020 Apr; 18(2):184-191. PubMed ID: 32092799
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic Efficacy of Exclusive Enteral Nutrition with Specific Polymeric Diet in Pediatric Crohn's Disease.
    Kang Y; Park S; Kim S; Kim SY; Koh H
    Pediatr Gastroenterol Hepatol Nutr; 2019 Jan; 22(1):72-79. PubMed ID: 30671376
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcomes of Pediatric Patients with Crohn's Disease Received Infliximab or Exclusive Enteral Nutrition during Induction Remission.
    Lv Y; Lou Y; Yang G; Luo Y; Lou J; Cheng Q; Yu J; Fang Y; Zhao H; Peng K; Chen J
    Gastroenterol Res Pract; 2022; 2022():3813915. PubMed ID: 36089982
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of Exclusive Enteral Nutrition on the Disease Process, Nutrition Status, and Gastrointestinal Microbiota for Chinese Children With Crohn's Disease.
    Tang W; Huang Y; Shi P; Wang Y; Zhang Y; Xue A; Tang Z; Hu W; Sun H; Zhang P; Zheng C; Shi J; Wang S; Qiu X; Lu X; Miao S; Meng Y
    JPEN J Parenter Enteral Nutr; 2021 May; 45(4):826-838. PubMed ID: 32510616
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of exclusive enteral nutrition in paediatric Crohn's disease in The Netherlands.
    de Bie C; Kindermann A; Escher J
    J Crohns Colitis; 2013 May; 7(4):263-70. PubMed ID: 22820027
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exclusive enteral nutrition with oral polymeric diet helps in inducing clinical and biochemical remission in adults with active Crohn's disease.
    Kakkadasam Ramaswamy P;
    JPEN J Parenter Enteral Nutr; 2022 Feb; 46(2):423-432. PubMed ID: 34618355
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Formula modifications to the Crohn's disease exclusion diet do not impact therapy success in paediatric Crohn's disease.
    Landorf E; Hammond P; Abu-Assi R; Ellison S; Boyle T; Comerford A; Couper R
    J Pediatr Gastroenterol Nutr; 2024 Jun; 78(6):1279-1286. PubMed ID: 38623960
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.